Need Help? Call 1­-866-­796-­7386
« back to stock screener

  KALV stock: Kalvista Pharmaceuticals Inc

Current Rating
Strong Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$16.44
Market Cap
426.4M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.73
P/S
-
Dividend %
-
P/CF
12.9
P/FCF
-
Op. Cash Flow
-44.3K
FCF
-2.0
Op. Margin
-
Net Margin
-
ROE
-33.00%
ROI
-
ROA
-30.60%
EPS Growth
-34.70%
Current Ratio
27.0
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Accuray Incorporated (ARAY) $4.43 - - 358.8M Strong Buy
Acer Therapeutics Inc (ACER) $2.30 - - 36.6M Strong Buy
AmerisourceBergen Corp. (ABC) $119.55 - 1.50% 24.82B Strong Buy
Assertio Holdings Inc (ASRT) $1.04 - - 40.3M Strong Buy
Bausch Health Companies Inc (BHC) $27.76 - - 10B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More